Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
J Majumder, T Minko - Expert opinion on drug delivery, 2021 - Taylor & Francis
Introduction Nanocarrier-based delivery systems offer multiple benefits to overcome
limitations of the traditional drug dosage forms, such as protection of the drug, enhanced …
limitations of the traditional drug dosage forms, such as protection of the drug, enhanced …
Inorganic nanoparticles for cancer therapy: a transition from lab to clinic
Background: Inorganic nanoparticles (NPs) including those derived from metals (eg, gold,
silver), semiconductors (eg, quantum dots), carbon dots, carbon nanotubes, or oxides (eg …
silver), semiconductors (eg, quantum dots), carbon dots, carbon nanotubes, or oxides (eg …
The blood–spinal cord barrier: morphology and clinical implications
V Bartanusz, D Jezova, B Alajajian… - Annals of …, 2011 - Wiley Online Library
The blood–spinal cord barrier (BSCB) is the functional equivalent of the blood–brain barrier
(BBB) in the sense of providing a specialized microenvironment for the cellular constituents …
(BBB) in the sense of providing a specialized microenvironment for the cellular constituents …
Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art
Glioblastoma multiforme, a grade IV glioma, is the most frequently occurring and invasive
primary tumor of the central nervous system, which causes about 4% of cancer-associated …
primary tumor of the central nervous system, which causes about 4% of cancer-associated …
From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood–brain barrier
The blood–brain barrier (BBB) is composed of brain endothelial cells, pericytes, and
astrocytes, which build a tight cellular barrier. Therapeutic (macro) molecules are not able to …
astrocytes, which build a tight cellular barrier. Therapeutic (macro) molecules are not able to …
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
The endogenous transport mechanisms which occur in living organisms have evolved to
allow selective transport and processing operate on a scale of tens of nanometers. This …
allow selective transport and processing operate on a scale of tens of nanometers. This …
[HTML][HTML] Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
X Niu, J Chen, J Gao - Asian journal of pharmaceutical sciences, 2019 - Elsevier
Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease,
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …
[HTML][HTML] The nanomedicine revolution: part 1: emerging concepts
CL Ventola - Pharmacy and Therapeutics, 2012 - ncbi.nlm.nih.gov
The Nanomedicine Revolution - PMC Back to Top Skip to main content NIH NLM Logo Access
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC …
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC …
Exploiting intrinsic nanoparticle toxicity: the pros and cons of nanoparticle-induced autophagy in biomedical research
1. INTRODUCTION In his 1959 keynote lecture “There is plenty of room at the bottom”,
Richard Feynman introduced the concepts that would later form the basis of a new era of …
Richard Feynman introduced the concepts that would later form the basis of a new era of …
Molecular communication and nanonetwork for targeted drug delivery: A survey
UAK Chude-Okonkwo, R Malekian… - … Surveys & Tutorials, 2017 - ieeexplore.ieee.org
Molecular communication (MC) and molecular network (MN) are communication paradigms
that use biochemical signaling to achieve information exchange among naturally and …
that use biochemical signaling to achieve information exchange among naturally and …